Table 3. Detailed profile of 25 children whose myocardium recovered and VAD was explanted with long-term outcome as to recurrence of heart failure and survival.
| Patient No. | Gender | Age | Diagnosis | Duration of disease (days) | CPR | ECMO support/duration (days) | VAD | Duration of VAD (days) | Recurrence of heart failure | Duration of follow-up (years) | Long-term outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 4.7 years | Myocarditis | 12 | No | No | BVAD | 22 | No | 15,7 | Died |
| 2 | F | 5.9 years | Myocarditis | 8 | Yes | Yes/6 | BVAD | 11 | No | 2.5 | Died |
| 3 | M | 1.2 years | Myocarditis | 3 | No | No | BVAD | 13 | No | 19.1 | Alive |
| 4 | M | 14.2 years | DCMP | 7 | No | No | LVAD | 23 | No | 16.3 | Alive |
| 5 | F | 11 mo 12 days | Myocarditis | 10 | No | No | LVAD | 12 | No | 15.9 | Alive |
| 6 | F | 3.4 years | Arrhytmogenic cardiomyopathy Ebsteins’s anomaly | 30 | Yes | No | BVAD | 18 | No | 14.7 | Alive |
| 7 | F | 3 mo 15 days | Ischemic HF (postop BWG) | 1 | No | No | LVAD | 12 | No | 13.0 | Alive |
| 8 | M | 2 mo 9 days | Ischemic HF (postop BWG) | 1 | No | No | LVAD | 13 | No | 12.9 | Alive |
| 9 | M | 14 years | DCMP | 330 | Yes | Yes/19 | LVAD | 125 | No | 11.7 | Alive |
| 10 | F | 16.3 years | Graft failure post-heart transplantation | 5 | Yes | No | RVAD | 78 | No | 11.7 | Alive |
| 11 | F | 5 mo 6 days | Myocarditis | 30 | No | No | LVAD | 42 | No | 10.7 | Alive |
| 12 | F | 4 mo 11 days | DCMP | 110 | No | No | LVAD | 30 | No | 10.0 | Alive |
| 13 | M | 3 mo 28 days | Non-compaction CMP | 90 | No | No | LVAD | 63 | No | 3.4 | Died |
| 14 | M | 21 days | Myocarditis | 13 | No | No | LVAD | 36 | No | 8.3 | Alive |
| 15 | M | 1.25 | Myocarditis | 20 | Yes | No | LVAD | 43 | No | 7.8 | Alive |
| 16 | F | 3 mo 1 day | Postoperative HF after repeated corrections: CoA hypoplastic arch and VSD closure | 87 | Yes | No | LVAD | 65 | No | 5.7 | Alive |
| 17 | F | 1.3 years | DCMP | 480 | No | No | BVAD | 91 | No | 4.6 | Alive |
| 18 | F | 5 mo 15 days | DCMP | 150 | Yes | No | LVAD | 65 | No | 4.3 | Alive |
| 19 | F | 5 mo 9 days | DCMP | 10 | No | No | LVAD | 72 | No | 2.6 | Alive |
| 20 | F | 4 mo 13 days | Myocarditis | 19 | No | No | LVAD | 155 | No | 1.4 | Alive |
| 21 | M | 11.2 years | Myocarditis | 16 | No | No | BVAD | 124 | No | 7.7 | Alive |
| 22 | F | 1.7 years | Myocarditis | 7 | No | No | LVAD | 41 | No | 6.10 | Alive |
| 23 | M | 4.1 years | Myocarditis | 3 | No | No | LVAD | 85 | No | 6.1 | Alive |
| 24 | F | 1.3 years | DCMP | 45 | No | No | LVAD | 700 | No | 4.0 | Alive |
| 25 | F | 3 mo 11 days | Ischemic HF from coronary artery injury after AVSD correction | 1 | No | No | LVAD | 7 | Yes—3 mo after VAD explantation, then transplanted | 8.6 years | Died |
CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; VAD, ventricular assist device; AVSD, atrioventricular septal defect; BWG, Bland White Garland Syndrome; DCMP, dilated cardiomyopathy; HF, heart failure; VSD, ventricular septal defect.